Lambert Initiative for Cannabinoid Therapeutics Supplementary Scholarships
Highlights
| Value | Eligibility | Open date | Close date |
|---|---|---|---|
| $10,000 p.a (up to 3.5 years) |
|
Ongoing | Ongoing |
How to apply
No application required for the scholarship. Recipients will be nominated by the Academic Director and Deputy Academic Director of the Lambert Initiative, or their nominated delegates.
Benefits
The stipend is worth $10,000 stipend per year, for up to three years.
An extension for up to six months is available, subject to satisfactory academic performance and approval from the Academic Director and Deputy Academic Director of the Lambert Initiative.
Who's eligible
You must:
- have an unconditional offer of admissions or being currently enrolled to study full-time in a PhD at the Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre, University of Sydney
- not have completed more than one year of full-time study at the time of offer if you are a currently enrolled student
- conduct research on cannabinoid based treatments
- have preclinical or clinical research experience
- be in recipient of a primary scholarship from the University of Sydney that provides stipend allowance.
Background
A unique opportunity is available for outstanding PhD scholars to conduct research into the medicinal potential of cannabis and cannabinoids at the University of Sydney’s Brain and Mind Centre.
The research will be focused on the development and evaluation of cannabinoid-based treatments. We are looking to support a wide range of first-year PhD projects that involve the development and evaluation of cannabis-based treatments across the following areas:
- preclinical and/or clinical
- medicinal and/or analytical chemistry
- electrophysiology
- high throughput screening
- animal and cellular models of disease
- human psychopharmacology
- drug policy
- clinical trials.
1. Background
a. A unique opportunity is available for an outstanding PhD scholar to conduct research in the area medicinal potential of cannabis and the cannabinoids at the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre.
b. The research will be focused on the development and evaluation of cannabinoid-based treatments.
2. Eligibility
a. The Scholarship is offered subject to the candidate having an unconditional offer of admissions or being currently enrolled to study full-time in a PhD at the Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre, University of Sydney.
b. Currently enrolled candidates must not have completed more than one year of full-time study at the time of offer.
c. Candidates must conduct research on cannabinoid based treatments.
d. Candidates must also have preclinical or clinical research experience.
e. Candidates must also be in recipient of a primary scholarship from the University of Sydney that provides stipend allowance.
3. Selection Criteria
a. The successful applicant will be awarded the Scholarship on the basis of:
I. academic merit, and
II. area of study and research proposal.
b. The successful applicant will be awarded the Scholarship by the nomination and approval of the Academic Director and Deputy Academic Director of the Lambert Initiative, or their nominated delegates.
4. Value
a. The Scholarship will provide an annual stipend supplementary allowance of $10,000 per annum (fixed rate) for up to three years, subject to satisfactory academic performance.
b. An extension of the Scholarship of 6 months is available if the recipient holds a primary stipend Scholarship for the entire duration of the extension period along with the approval of the Academic Director and Deputy Academic Director of the Lambert Initiative.
c. Periods of study already undertaken towards the degree prior to the commencement of the Scholarship will be deducted from the maximum duration of the Scholarship excluding the potential extension period.
d. The Scholarship is for commencement in relevant research period in which it is offered and cannot be deferred or transferred to another area of research without prior approval from the Academic Director and Deputy Academic Director of the Lambert Initiative, or their nominated delegates.
e. No other amount is payable.
f. The Scholarship will be offered subject to the availability of funding.
5. Eligibility for Progression
a. Progression is subject to passing the annual progress evaluation meeting.
6. Leave Arrangements
a. The same conditions as indicated in the terms and conditions of the primary scholarship, excluding any additional sick leave and parental leave.
7. Research Overseas
b. The same conditions as indicated in the terms and conditions of the primary scholarship.
8. Suspension
a. The same conditions as indicated in the terms and conditions of the primary scholarship.
9. Changes in Enrolment
a. The Scholarship recipient must notify HDRAC, Lambert Initiative for Cannabinoid Therapeutics at the Brain and Mind Centre and their supervisor promptly of any planned changes to their enrolment including but not limited to: attendance pattern, suspension, leave of absence, withdrawal, course transfer, and candidature upgrade or downgrade. If the award holder does not provide notice of the changes identified above, the University may require repayment of any overpaid stipend.
10. Termination
a. The Scholarship will be terminated:
I. on resignation or withdrawal of the recipient from their research degree,
II. upon submission of the thesis or at the end of the award,
III. if the recipient ceases to be a full-time student and prior approval has not been obtained to hold the Scholarship on a part-time basis the Academic Director and Deputy Academic Director of the Lambert Initiative, or their nominated delegates,
IV. upon the recipient having completed the maximum candidature for their degree as per the University of Sydney (Higher Degree by Research) Rule 2011 Policy,
V. on receipt of another supplementary stipend scholarship(s) that increases the overall supplementary amount paid to a student to more than 75% of the primary amount. In such circumstances, the supplementary stipend scholarship of the higher value prevails,
VI. if the recipient does not resume study at the end of a period of approved leave, or
VII. if the recipient ceases to meet the eligibility requirements specified for this Scholarship, (other than during a period in which the Scholarship has been suspended or during a period of approved leave).
b. The Scholarship may also be terminated by the University before this time if, in the opinion of the University:
I. the course of study is not being carried out with competence and diligence or in accordance with the terms of this offer,
II. the student fails to maintain satisfactory progress, or
III. the student has committed misconduct or other inappropriate conduct.
c. The Scholarship will be suspended throughout the duration of any enquiry/appeal process.
d. Once the Scholarship has been terminated, it will not be reinstated unless due to University error.
11. Misconduct
a. Where during the Scholarship a student engages in misconduct, or other inappropriate conduct (either during the Scholarship or in connection with the student’s application and eligibility for the Scholarship), which in the opinion of the University warrants recovery of funds provided, the University may require the student to repay payments made in connection with the Scholarship. Examples of such conduct include and without limitation; academic dishonesty, research misconduct within the meaning of the Research Code of Conduct 2023 (for example, plagiarism in proposing, carrying out or reporting the results of research, or failure to declare or manage a serious conflict of interests), breach of the Student Charter 2020 and misrepresentation in the application materials or other documentation associated with the Scholarship.
b. The University may require such repayment at any time during or after the Scholarship period. In addition, by accepting this Scholarship, the student consents to all aspects of any investigation into misconduct in connection with this Scholarship being disclosed by the University to the funding body and/or any relevant professional body.
12. Other requirements
a. The scholarship holder must share the outcome and content of their annual progress review to the Operations Committee of the Lambert Initiative for Cannabinoid Therapeutics. This committee is constituted by the Operations Manager, the Academic Director or Deputy Academic Director of the Lambert Initiative for Cannabinoid Therapeutics, or their nominated delegates.